Former FDA Officials Say Fosamax Claims Aren't Barred

By Emily Field · May 30, 2023, 6:42 PM EDT

Former U.S. Food and Drug Administration officials told the Third Circuit if it rules that patients' claims that Merck failed to warn that its osteoporosis drug Fosamax caused certain fractures are...

To view the full article, register now.

Documents

Case Information

Case Title

In re: Fosamax (Alendronate Sodium) Products Liabi

Case Number

22-3412

Court

Appellate - 3rd Circuit

Nature of Suit

4365 Personal Injury-Product Liability

Date Filed

December 22, 2022